Related Experiment Video
Updated: Jun 11, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left Atrioventricular Coupling Index in Health and Disease: A Longitudinal Multicohort Analysis
Roman Roy1, Janek Salatzki2, Liliana Szabo3
1William Harvey Research Institute, National Institute for Health Research Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, EC1A 7BE, London, UK.
The Left Atrioventricular Coupling Index (LACI) predicts atrial fibrillation (AF) and heart failure (HF) independently. New reference thresholds enable wider clinical use of this novel imaging biomarker.
Area of Science:
- Cardiology
- Medical Imaging
- Biomarkers
Background:
- Left Atrioventricular Coupling Index (LACI) is a novel imaging biomarker for LA-LV coupling.
- Undefined reference thresholds and uncertain predictive value limit LACI's clinical use.
Purpose of the Study:
- Investigate demographic variations and establish reference thresholds for LACI.
- Characterize LACI's relationship with cardiac structure and function.
- Evaluate LACI's incremental predictive value for cardiovascular outcomes.
Main Methods:
- Utilized two large datasets (Healthy Hearts Consortium, UK Biobank) with Cardiovascular Magnetic Resonance (CMR).
- Determined LACI reference thresholds using the 95% prediction interval method.
- Assessed LACI associations with cardiac parameters and incident cardiovascular outcomes (AF, HF) via regression models.
Main Results:
- Higher LACI observed in older individuals, non-White ethnicities, and women.
- Increased LACI associated with poorer LA function and higher LV filling pressures.
- LACI independently predicted incident AF and HF in UK Biobank, with raised LACI indicating higher event probability.
Conclusions:
- LACI is a robust predictor of AF and HF, offering incremental value over existing markers.
- Population-specific reference thresholds facilitate broader clinical implementation of LACI.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
